Menta Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Menta Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-27,513	Closed	-$511K	–	1050
2016 Q3	$511K	Sell	27,513 -4,389	-14%	-$82.8K	0.05%	568
2016 Q2	$520K	Buy	+31,902	New	+$469K	0.07%	501
2015 Q3	–	Sell	-18,300	Closed	-$173K	–	923
2015 Q2	$173K	Sell	18,300 -4,200	-19%	-$38.9K	0.03%	602
2015 Q1	$199K	Buy	+22,500	New	+$227K	0.03%	619

Other funds holding BEAT

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Menta Capital's BEAT Position: Q4 2016 in Review

Menta Capital sold out of BioTelemetry, Inc. (BEAT) in Q4 2016, closing a stake of 27,513 shares — an estimated $511K sold.

Menta Capital first reported a position in BEAT in Q1 2015 and held it in 4 quarters. The position peaked at $520K in Q2 2016. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

Menta Capital reported no remaining BioTelemetry, Inc. position as of Q4 2016 after selling out during the quarter.
Menta Capital sold 27,513 BioTelemetry, Inc. shares in Q4 2016, an estimated $511K.
Menta Capital first reported a position in BioTelemetry, Inc. in Q1 2015 and held it in 4 quarters.
Menta Capital's BioTelemetry, Inc. position peaked at $520K in Q2 2016.
160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on Menta Capital's 13F filing for Q4 2016, filed 14 Feb 2017.